Singapore Inks MoU with Quantinuum

Enabling Access to their Advanced Quantum Computer

July 24, 2024
A group of men sitting at a table with papersDescription automatically generated
[From left to right, seated] The MoU signing was represented by Dr. Su Yi, Executive Director, A*STAR’s Institute of High Performance Computing; Mr Ling Keok Tong, Executive Director, National Quantum Office; Prof José Ignacio Latorre, Director, Centre for Quantum Technologies; Dr. Rajeeb Hazra, President & CEO, Quantinuum, Dr. Sebastian Maurer-Stroh, Executive Director, A*STAR’s Bioinformatics Institute; Prof Thomas M. Coffman, Dean, Duke-NUS Medical School; Dr. Terence Hung, Chief Executive, National Supercomputing Centre Singapore.
[From left to right, standing] The MoU signing was witnessed by Prof Tan Sze Wee, Assistant Chief Executive, Biomedical Research Council, A*STAR; Prof Yeo Yee Chia, Assistant Chief Executive, Innovation & Enterprise, A*STAR; Prof Low Teck Seng, Co-chair, National Quantum Steering Committee; Mr Quek Gim Pew, Co-chair, National Quantum Steering Committee; Mr Ilyas Khan, Founder & Chief Product Officer, Quantinuum

Singapore, July 24th, 2024 — Singapore’s National Quantum Office (NQO), Agency for Science, Technology and Research (A*STAR), National University of Singapore (NUS), National Supercomputing Centre (NSCC) and Quantinuum signed a Memorandum of Understanding (MoU) today, enabling access to Quantinuum’s advanced quantum computer, and to explore and collaborate on quantum computing use cases, focusing on computational biology.

Under the MoU, the parties agree to leverage Quantinuum’s H-Series and Helios quantum computers, to promote joint research and development (R&D) activities in various quantum computing applications. Helios is Quantinuum’s next generation quantum processor that could exponentially increase the computing power of quantum computers. 

The parties will also collaborate on developing hybrid computing solutions that include both classical and quantum computing infrastructures, leading to the creation of long-term strategic roadmaps. The MoU also enables collaborations in training and outreach through seminars, workshops and bespoke programmes to nurture quantum talent and contribute towards Singapore’s growing quantum community. 

Singapore has a strong background in computational biology and the collection of quality health datasets. Through this MoU, scientists from A*STAR’s Bioinformatics Institute (A*STAR’s BII), the Centre for Quantum Technologies (CQT) at NUS and Duke-NUS Medical School’s Centre for Computational Biology will be able to leverage Quantinuum’s machines to enhance capabilities in modelling complex biological systems, advancing drug discovery and personalised medicine. In addition, Quantinuum also plans to establish a dedicated R&D presence in Singapore, where researchers from both Quantinuum and Singapore could better exchange knowledge and expertise for further developments in quantum applications and algorithms.

As the largest quantum computing company that has demonstrated success in building the highest performing quantum computers, Quantinuum offers an integrated, end-to-end quantum computing platform. Quantinuum leverages trapped-ion technology – one of the most promising approaches for building the highest fidelity and scalable quantum computers - to develop use cases in a wide range of applications, including pharmaceuticals, material sciences, and finance. 

This MoU is guided by Singapore’s National Quantum Strategy, which aims to strengthen Singapore’s position as a leading hub in the development and deployment of quantum technologies by bolstering scientific excellence in high impact areas of quantum research; strengthening Singapore’s engineering capabilities in quantum technologies to accelerate translation into real world solutions; attracting, developing and retaining quantum talent; and anchoring company partnerships to build a vibrant and resilient quantum industry. 

NQO oversees the development and execution of Singapore’s National Quantum Strategy to advance Singapore’s quantum technologies, talent and ecosystem development through the national-level quantum programmes. The National Quantum Computing Hub (NQCH), a national-level quantum programme and a joint initiative of CQT, A*STAR’s Institute of High Performance Computing (A*STAR’s IHPC) and the National Supercomputing Centre Singapore, will drive this collaboration with Quantinuum. 

“This is a strategic collaboration with Quantinuum, following the launch of Singapore’s National Quantum Strategy in late May. Through the NQCH, the National Quantum Office has brought together key research performers to collaborate with Quantinuum on advancing R&D in quantum computing, which will give Singapore an edge in quantum use cases across various industries. Equally important, this MoU will give Singapore access to Quantinuum’s state-of-the-art H-Series and Helios quantum computers. The NQO will continue to foster mutually beneficial partnerships through our national-level quantum programmes, and we look forward to delivering outcomes that could benefit the research, innovation and enterprise (RIE) ecosystem together,” said Ling Keok Tong, Executive Director, NQO.

"Our collaboration underscores our commitment to advancing global quantum computing. By harnessing our cutting-edge H-Series quantum computers and leading quantum application software stack, we aim to pioneer transformative use cases in computational biology and life sciences, catalysing innovation across industries. Establishing an R&D hub in Singapore enhances our dedication to fostering a vibrant quantum ecosystem, driving scientific excellence, and nurturing top quantum talent. Together, we aim to make significant strides in quantum technologies, supporting Singapore's ambition to lead in the rapidly evolving technological landscape," stated Dr. Rajeeb (Raj) Hazra, CEO of Quantinuum.

About the National Quantum Office

The National Quantum Office (NQO) was established with the support of the National Research Foundation (NRF) to drive the development and implementation of the Research, Innovation and Enterprise (RIE) strategy for Quantum in Singapore. The Office was set up in April 2022 and is hosted by A*STAR, the Implementing Agency for Quantum. NQO, as a control tower, supports fundamental and translational research in Quantum through various strategic programmes that it oversees. It partners both public and private sectors to create a vibrant RIE quantum ecosystem in Singapore. For more information, visit https://nqo.sg.

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is Singapore’s lead public sector R&D agency. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit the economy and society. As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by improving societal outcomes in healthcare, urban living, and sustainability. A*STAR plays a key role in nurturing scientific talent and leaders for the wider research community and industry. A*STAR’s R&D activities span biomedical sciences to physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis. For ongoing news, visit www.a-star.edu.sg.

Follow us on

Facebook | LinkedIn | Instagram | YouTube | TikTok

About Quantinuum 

Quantinuum, the world’s largest integrated quantum computing company, pioneers powerful quantum computers and advanced software solutions. Quantinuum’s technology drives breakthroughs in materials discovery, cybersecurity, and next-gen quantum AI. With over 500 employees, including 370+ scientists and engineers, Quantinuum leads the quantum computing revolution across continents.

About Duke-NUS Medical School

Duke-NUS is Singapore’s flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted ‘Clinicians Plus’ poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five signature research programmes and 10 centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore’s largest healthcare group. This strategic alliance has led to the creation of 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives.

For more information, please visit www.duke-nus.edu.sg

About the Centre for Quantum Technologies

The Centre for Quantum Technologies (CQT) is Singapore’s flagship national research centre in quantum technologies. Supported under Singapore’s National Quantum Strategy, the centre has nodes at partner institutions and coordinates research talent across the country.

CQT’s partner institutions are universities – the National University of Singapore, Nanyang Technological University, Singapore, and the Singapore University of Technology and Design – and the Agency for Science, Technology and Research.

CQT brings together physicists, computer scientists and engineers to do basic research on quantum physics and to build devices based on quantum phenomena. Experts in this new discipline of quantum technologies are applying their discoveries in computing, communications, and sensing.

For more information, please visit www.quantumlah.org

About the National Supercomputing Centre Singapore

Established in 2015, the National Supercomputing Centre (NSCC) Singapore manages Singapore’s first national Petascale facility providing high performance computing (HPC) resources. As a National Research Infrastructure, NSCC supports private and public sector research including commercial companies, government agencies as well as higher education and research institutes. Through the support of its stakeholders including the Agency for Science Technology and Research (A*STAR); Nanyang Technological University (NTU); National University of Singapore (NUS); Singapore University of Technology and Design (SUTD); the National Environment Agency (NEA) and Technology Centre for Offshore and Marine, Singapore (TCOMS); and funded by the National Research Foundation (NRF), NSCC catalyses national research and development initiatives, attracts industrial research collaborations and enhances Singapore’s research capabilities. For more information, please visit: https://nscc.sg

ANNEX – Additional quotes from MoU signatories

“A*STAR’s BII is excited to bring its expertise in Computational Biology and Bioinformatics approaches to accelerate the development of quantum-classical hybrid algorithms, quantum algorithms, and applications through this MoU. The MoU will also facilitate knowledge exchange to enhance our understanding of quantum technologies, positioning us at the forefront of innovation in these critical fields,” said Dr. Sebastian Maurer-Stroh, Executive Director, A*STAR’s Bioinformatics Institute.

“Right now, many promising biological discoveries stall when it comes to finding the right drug candidate that is not only effective at treating the disease but is also well-tolerated by patients. The process of finding the right molecule is slow and often limited in how many variables can be accounted for in a single model. Augmenting our existing capabilities with quantum computing could resolve these limitations, leading to better drugs for patients faster,” said Associate Professor Enrico Petretto, Director of the Centre for Computational Biology at Duke-NUS, adding: “This partnership, which focuses on quantum applications in biology, will also benefit computational biologists-in-training seeking to deepen their understanding of how to incorporate quantum computing into their drug discovery work.”

“A*STAR’s IHPC has been harnessing central processing units (CPUs) and graphics processing units (GPUs) to accelerate complex computations and optimise data-intensive tasks. With advancements in quantum computing technology, we are now integrating quantum processing unit (QPU) elements to push computational boundaries and drive innovation across various fields. Our partnership with Quantinuum is a step forward in improving applications such as drug discovery, potentially accelerating the development of new and effective drugs to improve healthcare outcomes and lower research costs”, said Dr. Su Yi, Executive Director, A*STAR’s Institute of High Performance Computing.

"I am excited to start this new collaboration between our scientific experts in Singapore and the multinational company Quantinuum. We bring know-how in quantum algorithms and computational biology to work with the Quantinuum team, which is building some of the highest performing quantum computers available in the world today," said Professor José Ignacio Latorre, CQT Director and lead Principal Investigator for the National Quantum Computing Hub.

“The past year has seen a worldwide trend of accelerated efforts to integrate and co-locate supercomputers and quantum computers, which reflects the strong symbiotic relationship between classical and quantum systems. Singapore’s tie-up with Quantinuum will be a significant step in helping NSCC learn, plan and develop our future hybrid computing infrastructure to serve the needs of our research community,” said Terence Hung, Chief Executive, National Supercomputing Centre Singapore.

“This partnership with Quantinuum will boost Singapore’s digital ecosystem as researchers and companies will be able to participate in the development and experimentation of advanced quantum-based techniques. Quantinuum’s investment in Singapore will deepen our capabilities in Quantum Computing and catalyse innovation in globally relevant areas of scientific discovery such as computational biology," said Philbert Gomez, Vice President and Head, Digital Industry Singapore.

About Quantinuum

Quantinuum, the world’s largest integrated quantum company, pioneers powerful quantum computers and advanced software solutions. Quantinuum’s technology drives breakthroughs in materials discovery, cybersecurity, and next-gen quantum AI. With over 500 employees, including 370+ scientists and engineers, Quantinuum leads the quantum computing revolution across continents. 

August 19, 2025
Mitsui, QSimulate, and Quantinuum Launch “QIDO”: A Quantum-Integrated Chemistry Platform Targeting Faster Drug and Materials Discovery

Tokyo, Japan, August 19th, 2025 — Mitsui & Co., Ltd. (“Mitsui”), QSimulate, and Quantinuum today announced the launch of a new quantum-integrated chemistry platform, QIDO (Quantum-Integrated Discovery Orchestrator). This platform aims to reduce the time and cost of developing new drugs and materials. QIDO accelerates research and development through high-precision chemical reaction modeling and seamlessly combines the advantages of cutting-edge classical computing and quantum computing.

Built for commercial impact, QIDO streamlines complex quantum-classical hybrid workflows and helps companies make decisions earlier in the development process, contributing to a powerful competitive advantage in innovation. The platform is designed to support research across an array of chemistry-based fields, including advanced materials design, clean energy, and drug development.

Proprietary Technology Supporting QIDO

QIDO seamlessly integrates QSimulate's software “QSP Reaction,” which enables calculations on the scale of thousands of atoms using the highest precision classical quantum chemistry methods and techniques. QIDO also integrates with Quantinuum's “InQuanto" software, which interfaces with state-of-the-art quantum emulators and world-leading Quantinuum Systems hardware. InQuanto™ achieves up to 10 times higher accuracy in simulations of complex molecules and materials compared to open-source software.

  • Makoto Koshida, General Manager, Quantum Innovation Department, Mitsui: “We take a market-needs-based approach, aiming to bridge the gap between providing practical features that help customers solve today's challenges and preparing them for the coming quantum era. This approach enables customers to maximize its benefits from day one when quantum technology comes into its own.”
  • Toru Shiozaki, Ph.D., President & CEO, QSimulate: “Combining best-in-class quantum chemical simulation with deep quantum computing expertise, QIDO gives industrial chemists powerful, intuitive algorithms and tools to tackle complex chemical challenges with speed and accuracy. We are excited about the marriage between years of innovation in quantum chemistry automation and the future of quantum computation.”
  • Dr. Rajeeb Hazra, President & CEO, Quantinuum: “Adding the benefits of chemical accuracy and computational efficiency of quantum-native simulations in applications of chemistry is a key step forward in revolutionizing the economics of discovery in several significant end markets, such as pharmaceuticals and energy. Quantinuum is proud to offer the industry's highest-performing quantum computers and widely used quantum chemistry software to enable this progress.”
QIDO Use Cases and Future Expansion

QIDO is launched together with a high-precision chemical reaction analysis module based on the so-called active space approach. Potential use cases are as follows:

  • Catalysts and enzyme design: Simulating complex electron behavior to inform high-efficiency catalysts and enzymes design for cleaner energy, greener manufacturing, and advanced biocatalysis (useful in drug discovery, food processing, biofuel, etc.).
  • Reaction mechanism elucidation: Enabling deeper understanding of complex chemical reaction pathways, including transient intermediates and excited states, for material stability, performance, and lifetime improvements.
  • Battery efficiency and energy storage: Enhancing battery materials and performance for safer, longer-lasting, and higher-capacity energy storage.
  • Sustainable materials and energy: Advancing energy-efficient materials, improving carbon capture and reuse, and supporting green ammonia and hydrogen production.

QIDO will gradually add new features to accelerate innovation in high-impact use cases, such as battery innovation and drug development. Innovation in these fields through quantum technology will be realized through 'co-creation' with our customers.

Feedback from Industry Leaders

As QIDO's exclusive distributor in Japan and a strategic partner with an eye toward future “co-creation,” Mitsui & Co. is leading domestic sales and distribution, laying the foundation for future global expansion. Prior to the general release of QIDO in the Japanese market, Mitsui & Co. conducted beta testing with three industry-leading companies.

  • JSR Corporation: “The platform provided by QSimulate lowers the barriers to computation by simplifying input, automating error handling, and focusing output on necessary information, making it an integral tool in the daily workflows of synthetic organic chemists at JSR. With this platform now extended to support quantum chemistry calculations on quantum computers via InQuanto, it offers a path to an early quantum advantage.” – Yu-ya Ohnishi, Ph.D., Research Fellow & Deputy Director, R&D Technology & Digital Transformation Center, Materials Informatics Promotion Office
  • Panasonic Holdings Corporation: “This platform provides users with a tool to intuitively perform chemical reaction simulations through a graphical user interface. In the anticipated era of large-scale fault-tolerant quantum computing, materials simulation is regarded as a promising application domain. Integrated with quantum computing, this platform is expected to offer opportunities for early-stage validation in preparation for future breakthroughs.” – Takahiro Ohgoe, Ph.D., Senior Lead Researcher, Green Innovation Center, Green Transformation Division
  • Chugai Pharmaceutical: “This application offers an intuitive interface that combines user-friendly operability with clear, instantly interpretable result visualization—making reaction pathway exploration easier and more efficient than ever. At present, we recognize several technical challenges in applying the system to complex molecular calculations encountered in drug discovery and pharmaceutical research. As these challenges are steadily addressed, we expect this application to play a meaningful role in accelerating and optimizing the synthesis and process development of candidate molecules with complex chemical structures—ultimately contributing to innovation in drug discovery and the advancement of pharmaceutical development.” – Akihiko Arakawa, Ph.D., Data Science Group, Digital Solution Dept., Digital Transformation Unit
Notable Functions of QIDO

QIDO is equipped with various functions to streamline high-precision chemical modeling. This makes quantum chemistry technology, which was previously only available to experts, more accessible for use in industrial settings.

  • Automatically identify reaction coordinates and transition states from specified reactants and products;
  • Map strongly correlated systems to compact Hamiltonians using quantum embedding and automated active space selection techniques;
  • Support customizable active spaces and computational methods to balance accuracy and cost;
  • Provides optimized energy calculations for reactants, products, and transition states using quantum hardware and their emulators;
  • Visualizes quantum circuits and reports the required quantum resources.

For purchases, trial applications, and other details, please visit: https://mitsui-q.com/en/qido/.

About Mitsui & Co., Ltd.

Mitsui & Co. is a global trading and investment company with a presence in more than 60 countries and a diverse business portfolio covering a wide range of industries.

The company identifies, develops, and grows its businesses in partnership with a global network of trusted partners including world leading companies, combining its geographic and cross-industry strengths to create long-term sustainable value for its stakeholders.

Mitsui has set three key strategic initiatives for its current Medium-term Management Plan: supporting industries to grow and evolve with stable supplies of resources and materials, and providing infrastructure; promoting a global transition to low-carbon and renewable energy; and empowering people to lead healthy lives through the delivery of quality healthcare and access to good nutrition.

For more information, please visit: https://www.mitsui.com/jp/en/index.html

About QSimulate

Founded in 2019 and headquartered in Boston, MA, QSimulate is a leader in quantum simulation technology for materials development and life sciences. The company offers a range of products and services designed to leverage the power of quantum mechanics to solve industrial-scale problems like never before.

For more information, please visit: https://qsimulate.com/

About Quantinuum

Quantinuum is the world leader in quantum computing. The company’s quantum systems deliver the highest performance across key industry benchmarks. Quantinuum’s over 550 employees, including 370+ scientists and engineers, across the US, UK, Germany, and Japan, are driving the quantum computing revolution.

For more information, please visit: https://www.quantinuum.com

This is some text inside of a div block.
All
This is some text inside of a div block.
All
This is some text inside of a div block.
All
May 20, 2025
Invest Qatar partners with Quantinuum to accelerate expansion and advance the region’s quantum computing ecosystem

Doha, Qatar, May 20th, 2025 — Invest Qatar, the Investment Promotion Agency of Qatar, has inked a strategic agreement with Quantinuum, the world leader in quantum computing and developer of the world’s highest-performing quantum computer. The partnership aims to strengthen Qatar’s quantum computing ecosystem by supporting Quantinuum’s recently announced expansion into the region, which was highlighted last week by the President of the United States during his historic state visit to Qatar.

Through this partnership, Invest Qatar will provide tailored support services to Quantinuum, including access to key stakeholders, sector-specific insights and opportunities for collaboration with local innovation and research institutions. Invest Qatar will also promote initiatives that drive quantum computing adoption and raise awareness of Quantinuum’s contributions to Qatar’s tech landscape. Through this partnership, Invest Qatar will support Quantinuum’s expansion into the country to apply quantum technologies for the benefit of key sectors in Qatar, while enhancing local research and development (R&D) capabilities, to create high-skilled jobs and train the next generation quantum workforce in Qatar. This includes facilitating connections with key stakeholders, enabling collaboration in R&D, and aligning with national initiatives aimed at advancing quantum technologies.

As part of the agreement, Quantinuum will play a central role in advancing Qatar’s quantum capabilities by launching a range of targeted initiatives, including knowledge-sharing platforms, educational seminars and technical workshops delivered by Quantinuum’s global experts. The partnership also envisions launching joint research projects with Qatari academic and research institutions, exploring opportunities for local integration of quantum technologies and facilitating access to Quantinuum’s cutting-edge quantum computing infrastructure. Additionally, internship opportunities will be offered to students from Qatar-based universities, providing direct experience in real-world quantum computing applications.

Commenting on the partnership, Sheikh Ali Alwaleed Al-Thani, CEO, Invest Qatar, said: “This partnership with Quantinuum reflects our continued commitment to positioning Qatar at the forefront of next-generation technologies. By combining global expertise with local ambition, we aim to cultivate a thriving quantum ecosystem that drives innovation, supports economic diversification and empowers future talent. We are pleased to work with Quantinuum to unlock the transformative potential of quantum computing for Qatar and the wider region.”

Dr. Rajeeb Hazra, President & CEO, Quantinuum, said: “Launching our presence in Qatar opens an exciting new chapter in a region ready to lead in quantum computing. Building on our recently announced expansion into the country through our joint venture with Al Rabban Capital, and our ongoing partnership with Hamad Bin Khalifa University, this collaboration with Invest Qatar reinforces our commitment to the growth of Qatar’s quantum computing ecosystem. As part of the deepening strategic ties between the U.S. and Qatar, we’re enabling direct access to our world-leading quantum hardware and software, creating value for academia and industry in Qatar while training the next generation of quantum developers and researchers to strengthen the region’s position as a global hub for advanced technologies.”

About Invest Qatar

The Investment Promotion Agency Qatar (Invest Qatar) is responsible for overseeing investment promotion activities, aimed at attracting foreign direct investment to Qatar. Established in 2019, Invest Qatar’s mission is to strengthen Qatar’s position as an ideal investment destination, while facilitating investments that foster economic diversification and development.

As the gateway to investment solutions, Invest Qatar connects investors to an integrated ecosystem of business and licensing platforms. The Agency partners with investors throughout their journey, from exploration and setup to expansion, ensuring their long-term growth by providing comprehensive insights into Qatar’s business landscape, sector-specific market knowledge and tailored investment facilitation.

For more information, please visit www.invest.qa

@InvestQatar | #InvestQatar

About Quantinuum    

Quantinuum is the world leader in quantum computing. The company’s quantum systems deliver the highest performance across all industry benchmarks. Quantinuum’s over 550 employees, including 370+ scientists and engineers, across the US, UK, Germany, and Japan, are driving the quantum computing revolution.  

For more information, please visit www.quantinuum.com

This is some text inside of a div block.
All
This is some text inside of a div block.
All
This is some text inside of a div block.
All
May 14, 2025
Quantinuum and Al Rabban Capital Launch Joint Venture to Accelerate Quantum Computing Adoption in Qatar and the Region

Doha, Qatar, May 14th, 2025 — Quantinuum, the world leader in quantum computing, is establishing a Qatari-incorporated Joint Venture with Al Rabban Capital, a division of Al Rabban Holding Company, one of Qatar’s most prominent companies. The Joint Venture will accelerate quantum computing adoption in Qatar and the region, strategically positioning the U.S. and Qatar as global leaders in the quantum revolution. This first of its kind quantum technology partnership was highlighted by the President of the United States during his historic state visit to Qatar.

The Joint Venture has three core objectives: enabling access to Quantinuum’s world-leading quantum technologies in the region; co-developing quantum computing applications tailored to regional needs in areas such as New Energy, Materials Discovery, Precision Medicine, Genomics, and Financial Services, with new opportunities emerging in the era of Generative Quantum AI (GenQAI); and, training the next generation of quantum computing developers in Qatar and the region.

Quantinuum is steadily expanding its global presence to meet the growing international demand for its technology and applications. The company’s expansion into the Gulf region, starting with Qatar, follows its successful growth across the U.S., U.K., Europe and Indo-Pacific. This Joint Venture reflects a shared commitment by the U.S. and Qatar to strengthen strategic ties, spur bilateral investment in future-defining industries, and foster technological leadership and shared prosperity.  

Quantinuum’s Joint Venture with Al Rabban Capital builds on its partnership announced last year with Hamad Bin Khalifa University and the Qatar Center for Quantum Computing (QC2), Qatar’s premier quantum research hub.

“This is a defining moment in Qatar’s ambition to become a regional hub for advanced technologies like quantum computing,” said Abdulaziz Khalid Al Rabban, Chairman, Al Rabban Capital. “We're partnering with Quantinuum to deliver world-class quantum solutions, driving economic growth in Qatar and the region.”

“This Joint Venture demonstrates our shared vision to lead in transformative technologies,” said Dr. Rajeeb Hazra, President & CEO of Quantinuum. “Together with Al Rabban Capital, we’re accelerating the commercial adoption of quantum computing in Qatar and the region whilst serving U.S. and Qatari strategic interests.”

About Quantinuum

Quantinuum is the world leader in quantum computing. The company’s quantum systems deliver the highest performance across key industry benchmarks. Quantinuum’s over 550 employees, including 370+ scientists and engineers, across the US, UK, Germany, and Japan, are driving the quantum computing revolution.

For more information, please visit: https://www.quantinuum.com

About Al Rabban Capital

Al Rabban Capital (ARC) is a Qatari investment and advisory firm driving business growth across Qatar and the GCC. ARC enable market entry and expansion through joint ventures, strategic partnerships, and deep local insight. ARC supports both public and private sector initiatives with tailored, end-to-end solutions. Beyond capital, ARC provide strategic guidance, governance, and access to a robust regional network. ARC’s focus includes AI, quantum tech, healthcare, and sustainability, with a commitment to impactful growth.

For more information, please visit: https://www.alrabbancapital.com

This is some text inside of a div block.
All
This is some text inside of a div block.
All
This is some text inside of a div block.
All